Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-05

Clinical Trial Update: Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

View source ↗

Summary

A completed clinical trial evaluating whether targeting glutamine metabolism can prevent cardiovascular complications in people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Glutamine, Diabetic | Status: COMPLETED